Understanding OR4K7P: A Potential Drug Target and Biomarker (G79306)

Understanding OR4K7P: A Potential Drug Target and Biomarker

OR4K7P (OR4K10P), a protein that belongs to the OR4K family of K-type ATP-binding proteins, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Its unique structure and function have made it an attractive target for drug development, as well as a valuable research tool for understanding the underlying mechanisms of these diseases.

OR4K7P is a 21-kDa protein that is expressed in various tissues, including brain, heart, and muscle. Its highly conserved catalytic core, which consists of a catalytic domain and a variable loop region, is responsible for the protein's unique ATP-binding properties. The catalytic domain of OR4K7P contains a catalytic loop and a Rossmann-fold, which are both known to be important for protein-protein interactions and ATP binding. The variable loop region, which is located between the catalytic domain and the Rossmann-fold, is involved in the regulation of ATP binding and release.

OR4K7P has been shown to play a role in various physiological processes, including cell signaling, metabolism, and inflammation. For example, OR4K7P has been shown to be involved in the regulation of cell adhesion, cell migration, and the establishment of tissue boundaries. It has also been shown to play a role in the regulation of muscle contractions and the maintenance of muscle mass. In addition, OR4K7P has been linked to the development and progression of various psychiatric disorders, including depression, anxiety, and schizophrenia.

OR4K7P has also been shown to be a potential drug target for several diseases. For example, OR4K7P has been shown to be involved in the development and progression of cancer, both in human and animal models. Studies have shown that inhibition of OR4K7P can lead to the inhibition of the growth and survival of cancer cells. In addition, OR4K7P has also been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. The loss of OR4K7P has been linked to the development of these conditions, and the development of drugs that can specifically target OR4K7P has been shown to be effective in treating these conditions.

In addition to its potential as a drug target, OR4K7P also has potential as a biomarker. The OR4K7P gene has been shown to be expressed in various tissues and has been used as a target for techniques such as RNA interference, overexpression, and purification. These techniques can be used to study the function of OR4K7P and to identify potential new therapeutic targets. In addition, the OR4K7P gene has also been used to study the regulation of gene expression in various tissues and conditions, including cancer, neurodegenerative diseases, and psychiatric disorders.

In conclusion, OR4K7P is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Its unique structure and function make it an attractive target for drug development, as well as a valuable research tool for understanding the underlying mechanisms of these diseases. Further studies are needed to fully understand the role of OR4K7P in these conditions and to identify new therapeutic targets.

Protein Name: Olfactory Receptor Family 4 Subfamily K Member 7 Pseudogene

The "OR4K7P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR4K7P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR4L1 | OR4M1 | OR4M2 | OR4M2-OT1 | OR4N2 | OR4N3P | OR4N4 | OR4N5 | OR4P4 | OR4Q3 | OR4S1 | OR4S2 | OR4T1P | OR4V1P | OR4X1 | OR4X2 | OR51A1P | OR51A2 | OR51A3P | OR51A4 | OR51A6P | OR51A7 | OR51B2 | OR51B4 | OR51B5 | OR51B6 | OR51C1P | OR51D1 | OR51E1 | OR51E2 | OR51F1 | OR51F2 | OR51G1 | OR51G2 | OR51H1 | OR51I1 | OR51I2 | OR51J1 | OR51L1 | OR51M1 | OR51Q1 | OR51S1 | OR51T1 | OR51V1 | OR52A1 | OR52A4P | OR52A5 | OR52B2 | OR52B4 | OR52B6 | OR52D1 | OR52E1 | OR52E2 | OR52E4 | OR52E5 | OR52E6 | OR52E8 | OR52H1 | OR52I1 | OR52I2 | OR52J3 | OR52K1 | OR52K2 | OR52K3P | OR52L1 | OR52M1 | OR52N1 | OR52N4 | OR52N5 | OR52R1 | OR52W1 | OR52Z1P | OR56A1 | OR56A3 | OR56A4 | OR56A5 | OR56B1 | OR56B4 | OR5A1 | OR5A2 | OR5AC1 | OR5AC2 | OR5AK2 | OR5AK4P | OR5AN1 | OR5AP2 | OR5AR1 | OR5AS1 | OR5AU1 | OR5B12 | OR5B17 | OR5B2 | OR5B21 | OR5B3 | OR5BA1P | OR5C1 | OR5D13 | OR5D14 | OR5D16 | OR5D17P